Cargando…

Human papillomavirus detection in cervical neoplasia attributed to 12 high-risk human papillomavirus genotypes by region()

BACKGROUND: We estimated the proportion of cervical intraepithelial neoplasia (CIN) cases attributed to 14 HPV types, including quadrivalent (qHPV) (6/11/16/18) and 9-valent (9vHPV) (6/11/16/18/31/33/45/52/58) vaccine types, by region METHODS: Women ages 15–26 and 24–45 years from 5 regions were enr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castellsagué, Xavier, Ault, Kevin A., Bosch, F. Xavier, Brown, Darron, Cuzick, Jack, Ferris, Daron G., Joura, Elmar A., Garland, Suzanne M., Giuliano, Anna R, Hernandez-Avila, Mauricio, Huh, Warner, Iversen, Ole-Erik, Kjaer, Susanne K., Luna, Joaquin, Monsonego, Joseph, Muñoz, Nubia, Myers, Evan, Paavonen, Jorma, Pitisuttihum, Punnee, Steben, Marc, Wheeler, Cosette M., Perez, Gonzalo, Saah, Alfred, Luxembourg, Alain, Sings, Heather L, Velicer, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886863/ https://www.ncbi.nlm.nih.gov/pubmed/29074187 http://dx.doi.org/10.1016/j.pvr.2016.03.002

Ejemplares similares

Human papillomavirus seroprevalence and seroconversion following baseline detection of nine human papillomavirus types in young women
por: Brown, Darron R., et al.
Publicado: (2022)

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data
por: Joura, Elmar A, et al.
Publicado: (2012)

Prevalence, incidence, and natural history of HPV infection in adult women ages 24 to 45 participating in a vaccine trial
por: Ferris, Daron G., et al.
Publicado: (2020)

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
por: Garland, Suzanne M., et al.
Publicado: (2016)

Intention-to-prevent analyses for estimating human papillomavirus vaccine efficacy in clinical studies
por: Saah, Alfred, et al.
Publicado: (2017)

The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature
por: Taylor, Sylvia, et al.
Publicado: (2016)

The role of human papillomavirus in head and neck cancer in Senegal
por: Ndiaye, Cathy, et al.
Publicado: (2013)

Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
por: Kamolratanakul, Supitcha, et al.
Publicado: (2021)

Knowledge of Cervical Cancer and Acceptability of Prevention Strategies Among Human Papillomavirus-Vaccinated and Human Papillomavirus-Unvaccinated Adolescent Women in Eldoret, Kenya
por: Mburu, Anisa, et al.
Publicado: (2019)

Predictors of human papillomavirus infection in women undergoing routine cervical cancer screening in Spain: the CLEOPATRE study
por: Roura, Esther, et al.
Publicado: (2012)

Human papillomavirus vaccination: where to now?
por: Garland, S M
Publicado: (2011)

Long-term immunogenicity, effectiveness, and safety of nine-valent human papillomavirus vaccine in girls and boys 9 to 15 years of age: Interim analysis after 8 years of follow-up
por: Olsson, Sven-Eric, et al.
Publicado: (2020)

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
por: Lehtinen, Matti, et al.
Publicado: (2011)

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019)

Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women
por: Hernández-López, Rubí, et al.
Publicado: (2021)

Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review
por: Hartwig, Susanne, et al.
Publicado: (2012)

Human papillomavirus vaccination: the population impact
por: Lee, Lai-yang, et al.
Publicado: (2017)

Epidemiology and Natural History of Human Papillomavirus Infections in the Female Genital Tract
por: Ault, Kevin A.
Publicado: (2006)

Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico
por: Parada, Rocio, et al.
Publicado: (2010)

Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico
por: Parada, Rocio, et al.
Publicado: (2011)

Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age
por: Moreira, E. D., et al.
Publicado: (2017)

Multicenter Study of Human Papillomavirus and the Human Papillomavirus Vaccine: Knowledge and Attitudes among People of African Descent
por: Blackman, Elizabeth, et al.
Publicado: (2013)

Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants
por: Garland, Suzanne M., et al.
Publicado: (2022)

Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study
por: Albero, Ginesa, et al.
Publicado: (2013)

The Epidemiology of Human Papillomavirus Infection and Cervical Cancer
por: Bosch, F. Xavier, et al.
Publicado: (2007)

Effect of age-difference between heterosexual partners on risk of cervical cancer and human papillomavirus infection
por: Baussano, Iacopo, et al.
Publicado: (2017)

Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA
por: Castellsagué, Xavier, et al.
Publicado: (2014)

The influence of type-specific human papillomavirus infections on the detection of cervical precancer and cancer: A population-based study of opportunistic cervical screening in the United States
por: Wheeler, Cosette M, et al.
Publicado: (2014)

Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine – A combined analysis of five phase III clinical trials
por: Petersen, Lone K., et al.
Publicado: (2017)

Redetection of human papillomavirus type 16 infections of the cervix in mid-adult life
por: Ermel, Aaron, et al.
Publicado: (2018)

Human Papillomavirus Vaccination After COVID-19
por: Toh, Zheng Quan, et al.
Publicado: (2021)

Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in high-risk populations, Spain, 2016
por: Martínez-Gómez, Xavier, et al.
Publicado: (2019)

End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age
por: Castellsagué, X, et al.
Publicado: (2011)

Prevalence and determinants of human papillomavirus genital infection in men
por: Franceschi, S, et al.
Publicado: (2002)

Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia
por: Sauter, Sharon L., et al.
Publicado: (2021)

The Cape Town declaration on human papillomavirus related disease()
por: Williamson, Anna-Lise, et al.
Publicado: (2017)

Knowledge about human papillomavirus and the human papillomavirus vaccine in Belgian students
por: Deriemaeker, Hanne, et al.
Publicado: (2014)

Human Papillomavirus (HPV) infection in pregnant women and mother-to-child transmission of genital HPV genotypes: a prospective study in Spain
por: Castellsagué, Xavier, et al.
Publicado: (2009)

Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee
por: Taumberger, Nadja, et al.
Publicado: (2022)

High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up
por: Villa, L L, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_5519q256d8vsvkrtj5hv30g0gr